Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18 | 837 | 650 | 3,029 | 9,826 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,008 |
| Other current assets | 246 | 38 | 0 | 0 | 0 |
| TOTAL | $264 | $874 | $866 | $3,294 | $11,029 |
| Non-Current Assets | |||||
| PPE Net | 4 | 9 | 45 | 84 | 107 |
| Other Non-Current Assets | 98 | 366 | 71 | 71 | 71 |
| TOTAL | $102 | $375 | $115 | $154 | $177 |
| Total Assets | $366 | $1,249 | $981 | $3,448 | $11,206 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 473 | 542 | 1,280 | 1,393 | 1,618 |
| Accrued Expenses | N/A | 874 | 592 | 550 | 48 |
| Other current liabilities | 785 | N/A | N/A | N/A | N/A |
| TOTAL | $2,532 | $1,486 | $1,872 | $1,943 | $1,666 |
| Non-Current Liabilities | |||||
| Long Term Debt | 614 | 1,174 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 4,004 | 2,964 | 0 | 0 | 0 |
| TOTAL | $4,618 | $4,139 | $N/A | $N/A | $N/A |
| Total Liabilities | $7,151 | $5,625 | $1,872 | $1,943 | $1,666 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41 | 25 | 25 | 21 | 21 |
| Common Shares | 71 | 71 | 71 | 60 | 60 |
| Retained earnings | -61,933 | -59,268 | -54,999 | -42,967 | -33,272 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 1 |
| TOTAL | $-6,785 | $-4,376 | $-891 | $1,505 | $9,541 |
| Total Liabilities And Equity | $366 | $1,249 | $981 | $3,448 | $11,206 |